Investment of 350 million EUR in state-of-the-art research infrastructure is Boehringer Ingelheim’s largest single investment in Germany to date Boehringer Ingelheim strengthens innovation power and development of biopharmaceuticals, which account…
The Syntegon Group, a provider of processing and packaging technology, appointed Torsten Türling as new Chief Executive Officer (CEO). He succeeds Dr. Michael Grosse, who will leave the company by…